Skip to main content
Premium Trial:

Request an Annual Quote

Global Enterprises to Acquire Majority Stake in Predictive Therapeutics

NEW YORK(GenomeWeb) – Global Enterprises Group today said that it has reached a deal to acquire a majority stake in molecular diagnostics and therapeutics firm Predictive Therapeutics for an undisclosed amount. 

The deal is anticipated to be completed in 10 days, after which changes to Predictive's management and board will be announced, Global said. 

Predictive was organized to develop, commercialize, acquire, and invest in molecular diagnostic technologies, as well as therapeutic products, with plans to commercialize novel therapeutics developed through the use of gene-based companion diagnostics. 

Global is a diversified holding company based inVirginia Beach, Va.